Influence of the microenvironment of thiol groups in low molecular mass thiols and serum albumin on the reaction with methylglyoxal

Chemico-Biological Interactions

Volumn 188, Issue 1, 2010, Pages 21-30

  Aćimović, Jelena M ^a   Stanimirović, Bojana D ^a   Todorović, Nina ^b   Jovanović, Vesna B ^a   Mandić, Ljuba M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

HSA; Low molecular mass thiols; Methylglyoxal; Protein glycation; Thiol group reactivity and microenvironment

Indexed keywords

ACETYLCYSTEINE; CARBOCISTEINE; CYSTEINE; GLUTATHIONE; HUMAN SERUM ALBUMIN; METHYLGLYOXAL; SCAVENGER; THIOL GROUP; SERUM ALBUMIN; THIOL DERIVATIVE;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; HYDROPHOBICITY; MICROENVIRONMENT; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROPHOTOMETRY; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE;

ELECTROPHORESIS, POLYACRYLAMIDE GEL; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PYRUVALDEHYDE; SERUM ALBUMIN; SULFHYDRYL COMPOUNDS;

EID: 77956169770     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.07.013     Document Type: Article

References (49)

1. Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur. J. Biochem. 1993, 212:101-105.
2. Lapolla R., Flamini V.A., Dalla A., Senesi R., Reitano D., Fedele E., Basso R., Seraglia P., Traldi Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin. Chem. Lab. Med. 2003, 41:1166-1173.
3. McLellan A.C., Thornalley P.J., Benn J., Sonksen P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.) 1994, 87:21-29.
4. Odani H., Shinzato T., Matsumoto Y., Usami J., Maeda K. Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 1999, 256:89-93.
5. Thornalley P.J. Dicarbonyl intermediates in the maillard reaction. Ann. N. Y. Acad. Sci. 2005, 1043:111-117.
6. Lo T.W., Westwood M.E., McLellan A.C., Selwood T., Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem. 1994, 269:32299-32305.
7. Mera K., Takeo K., Izumi M., Maruyama T., Nagai R., Otagiri M. Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin. J. Pharm. Sci. 2010, 99:1614-1625.
8. Thornalley P.J. Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy. Biochem. Soc. Trans. 2003, 31:1372-1377.
9. Grillo M.A., Colombatto S. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids 2008, 35:29-36.
10. Yao D., Taguchi T., Matsumura T., Pestell R., Edelstein D., Giardino I., Suske G., Ahmed N., Thornalley P.J., Sarthy V.P., Hammes H.P., Brownlee M. Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Cell 2006, 124:275-286.
11. Baynes J.W., Thorpe S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med. 2000, 28:1708-1716.
12. Nagai R., Mera K., Nakajou K., Fujiwara Y., Iwao Y., Imai H., Murata T., Otagiri M. The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. Biochim. Biophys. Acta 2007, 1772:1192-1198.
13. Kalapos M.P. The tandem of free radicals and methylglyoxal. Chem. Biol. Interact. 2008, 171:251-271.
14. Ramasamy R., Yan S.F., Schmidt A.M. Methylglyoxal comes of AGE. Cell 2006, 124:258-260.
15. Morgan P.E., Dean R.T., Davies M.J. Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch. Biochem. Biophys. 2002, 403:259-269.
16. Zeng J., Davies M.J. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem. Res. Toxicol. 2005, 18:1232-1241.
17. Alt N., Carson J.A., Alderson N.L., Wang Y., Nagai R., Henle T., Thorpe S.R., Baynes J.W. Chemical modification of muscle protein in diabetes. Arch. Biochem. Biophys. 2004, 425:200-206.
18. Mostafa A.A., Randell E.W., Vasdev S.C., Gill V.D., Han Y., Gadag V., Raouf A.A., El S.H. Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Mol. Cell Biochem. 2007, 302:35-42.
19. Thorpe S.R., Baynes J.W. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003, 25:275-281.
20. Sharma K.K., Santhoshkumar P. Lens aging: effects of crystallins. Biochim. Biophys. Acta 2009, 1790:1095-1108.
21. Zeng J., Davies M.J. Protein and low molecular mass thiols as targets and inhibitors of glycation reactions. Chem. Res. Toxicol. 2006, 19:1668-1676.
22. Westwood M.E., Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J. Protein Chem. 1995, 14:359-372.
23. Acimovic J.M., Stanimirovic B.D., Mandic Lj.M. The role of thiol group in protein modification with methylglyoxal. J. Serb. Chem. Soc. 2009, 74:867-883.
24. Bourdon E., Blache D. The importance of proteins in defense against oxidation. Antioxid. Redox Signal. 2001, 3:293-311.
25. Faure P., Troncy L., Lecomte M., Wiernsperger N., Lagarde M., Ruggiero D., Halimi S. Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab. 2005, 31:169-177.
26. Faure P., Wiernsperger N., Polge C., Favier A., Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin. Sci. (Lond.) 2008, 114:51-256.
27. Edelstein D., Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 1992, 41:26-29.
28. Rahbar S., Figarola J.L. Novel inhibitors of advanced glycation endproducts. Arch. Biochem. Biophys. 2003, 419:63-79.
29. Ruggiero-Lopez D., Lecomte M., Moinet G., Patereau G., Lagarde M., Wiernsperger N. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem. Pharmacol. 1999, 58:1765-1773.
30. Wondrak G.T., Cervantes-Laurean D., Roberts M.J., Qasem J.G., Kim M., Jacobson E.L., Jacobson M.K. Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem. Pharmacol. 2002, 63:361-373.
31. Doumas B.T., Watson W.A., Biggs H.G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin. Chim. Acta 1971, 31:87-96.
32. Hoeffer Scientific Instruments Electrophoresis Instruments and Accessories. Techniques and Exercises 1991, Hoeffer Scientific Instruments, San Francisco.
33. Bulaj G., Kortemme T., Goldenberg D.P. Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry 1998, 37:8965-8972.
34. Bar-Or D., Bar-Or R., Rael L.T., Gardner D.K., Slone D.S., Craun M.L. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit. Care Med. 2005, 33:1638-1641.
35. Zaia D.A.M., Barreto W.J. Spectrophotometric method for simultaneous determination of proteins and amino acids with p-benzoquinone. Anal. Chim. Acta 1993, 277:89-95.
36. Pfenninger H. Brautechnische Analysenmethoden, Band II, Methodensammlung der Mitteleuropäischen Brautechnischen Analysenkommision (MEBAK) 1993, Auflage, Selbstverlag der MEBAK, Freising, p. 60. 3rd ed.
37. Sastry C.S.P., Tummuru M.K. Spectrophotometric determination of arginine in proteins. Food Chem. 1984, 15:257-260.
38. Gerstein M.A. Resolution-sensitive procedure for comparing protein surfaces and its application to the comparison of antigen-combining sites. Acta Crystallogr. 1992, A48:271-276.
39. Nemet I., Vikic-Topic D., Varga-Defterdarovic L. Spectroscopic studies of methylglyoxal in water and dimethylsulfoxide. Bioorg. Chem. 2004, 32:560-570.
40. Rae C., O'Donoghue S.I., Bubb W.A., Kuchel P.W. Stereospecificity of substrate usage by glyoxalase 1: nuclear magnetic resonance studies of kinetics and hemithioacetal substrate conformation. Biochemistry 1994, 33:3548-3559.
41. Chaplen W.R. Incidence and potential implications of the toxic metabolite methylglyoxal in cell culture: a review. Cytotechnology 1998, 26:173-183.
42. Thornalley P.J. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 1996, 27:565-573.
43. Sridharan S., Nicholls A., Honig B. A new vertex algorithm to calculate solvent acessible surface areas. Biophys. J. 1992, 61:A174.
44. Griffith R., Hammond E.G. Generation of Swiss cheese flavor components by the reaction of amino acids with carbonyl compounds. J. Dairy Sci. 1989, 72:604-613.
45. de S., Marchand R.G., Vercauteren J., Bertrand A. Possible mechanism for involvement of cysteine in aroma production in wine. J. Agric. Food Chem. 2002, 50:6160-6164.
46. Beisswenger P.J., Howell S.K., Touchette A.D., Lal S., Szwergold B.S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 1999, 48:198-202.
47. Pasaoglu H., Sancak B., Bukan N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J. Exp. Med. 2004, 203:211-218.
48. Neshich G., Mancini A.L., Yamagishi M.E., Kuser P.R., Fileto R., Pinto I.P., Palandrani J.F., Krauchenco J.N., Baudet C., Montagner A.J., Higa R.H. STING report: collection of graphic and tabular sequence structure and function descriptors for an individual amino acid of PDB structures. Nucleic Acids Res. 2005, 1(33 Database Issue):D269-D274.
49. Radzicka A., Wolfenden R. Comparing the polarities of the amino-acids - side-chain distribution coefficients between the vapor-phase, cyclohexane, 1-octanol, and neutral aqueous-solution. Biochemistry 1988, 27:1664-1670.